胃癌吻合口漏检测的疗效与安全性:一项随机对照试验
该随机对照试验纳入148例胃癌手术患者,随机分为术中漏检测组(IOLT)与无术中漏检测组(NIOLT),评估联合胃镜、空气与亚甲蓝(GAM)漏检测法的疗效与安全性。IOLT组术中5例(7.1%)发现吻合口缺陷,术后吻合口漏NIOLT组4例(5.8%)vs IOLT组0例(0%),未见GAM相关并发症。GAM法可安全有效地预防技术缺陷相关吻合口并发症。
要点
- GAM漏检测法在腹腔镜全胃切除术后可安全、高效地实施。
- IOLT组术中7.1%发现吻合口缺陷,包括吻合口不连续、出血和狭窄。
- 术后吻合口漏NIOLT组5.8% vs IOLT组0%,未见GAM相关并发症。
核心结论
- GAM漏检测法是一种可安全、高效地在腹腔镜全胃切除术后实施的术中漏检测方法。
- GAM吻合口漏检测可能有效预防胃癌胃切除术患者中技术缺陷相关的吻合口并发症。
研究设计与样本
- 前瞻性随机对照试验,在三级转诊教学医院开展,纳入18-85岁、CT确认无不可切除因素的胃癌患者。
- 初步随机分配148例患者至术中漏检测组(IOLT,n=74)与无术中漏检测组(NIOLT,n=74),2018年9月至2022年9月入组。
- 排除后IOLT组70例、NIOLT组68例;主要终点为两组术后吻合口相关并发症发生率。
主要发现
- IOLT组术中5例(7.1%)发现吻合口缺陷,包括吻合口不连续、出血和狭窄。
- NIOLT组术后吻合口漏发生率高于IOLT组:4例(5.8%)vs 0例(0%)。
- 未观察到GAM相关并发症。
关键数值与推荐
- IOLT组术中吻合口缺陷检出率为7.1%(5例)。
- 术后吻合口漏发生率NIOLT组5.8%(4例)vs IOLT组0%(0例)。
临床怎么用
- 在胃癌胃切除术中,可考虑采用GAM法进行术中吻合口漏检测以预防技术缺陷相关并发症。
- GAM法在腹腔镜全胃切除术后可安全实施,未见GAM相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anastomosis-related complications such as bleeding, leakage, and strictures, continue to be serious complications of gastric cancer surgery. Presently, these complications have yet to be reliably prevented. Here we design a comprehensive leak testing procedure which combines gastroscopy, air, and methylene blue (GAM) leak testing. We aimed to evaluated the efficacy and safety of the GAM procedure in patients with gastric cancer. METHODS: Patients aged 18-85 years without an unresectable factor as confirmed via CT were enrolled in a prospective randomized clinical trial at a tertiary referral teaching hospital and were randomly assigned to two groups: intraoperative leak testing group (IOLT) and no intraoperative leak testing group (NIOLT). The primary endpoint was the incidence of postoperative anastomosis-related complications in the two groups. RESULTS: 148 patients were initially randomly assigned to the IOLT group (n = 74) and to the NIOLT group (n = 74) between September 2018 and September 2022. After exclusions, 70 remained in the IOLT group and 68 in the NIOLT group. In the IOLT group, 5 patients (7.1%) were found to have anastomotic defects intraoperatively, which included anastomotic discontinuity, bleeding, and strictures. The NIOLT group had a higher incidence of postoperative anastomotic leakage compared to the IOLT group: 4 patients (5.8%) vs 0 patients (0%), respectively. No GAM-related complications were observed. CONCLUSION: The GAM procedure is an intraoperative leak test that can be performed safely and efficiently after a laparoscopic total gastrectomy. GAM anastomotic leak testing may effectively prevent technical defect-related anastomotic complications in patients with gastric cancer who undergo a gastrectomy. TRIAL REGISTRATION: Clinical Trials.gov Identifier: NCT04292496.
引用
- Gao Z, Luo H, Ma L, et al. Efficacy and safety of anastomotic leak testing in gastric cancer: a randomized controlled trial. Surg Endosc. 2023. PMID: 36971816. doi:10.1007/s00464-023-10025-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。